2iq9: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2iq9.jpg|left|200px]] | [[Image:2iq9.jpg|left|200px]] | ||
<!-- | |||
The line below this paragraph, containing "STRUCTURE_2iq9", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_2iq9| PDB=2iq9 | SCENE= }} | |||
}} | |||
'''PFA2 FAB fragment, triclinic apo form''' | '''PFA2 FAB fragment, triclinic apo form''' | ||
Line 19: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2IQ9 OCA]. | |||
==Reference== | ==Reference== | ||
Molecular basis for passive immunotherapy of Alzheimer's disease., Gardberg AS, Dice LT, Ou S, Rich RL, Helmbrecht E, Ko J, Wetzel R, Myszka DG, Patterson PH, Dealwis C, Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15659-64. Epub 2007 Sep 25. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/17895381 17895381] | Molecular basis for passive immunotherapy of Alzheimer's disease., Gardberg AS, Dice LT, Ou S, Rich RL, Helmbrecht E, Ko J, Wetzel R, Myszka DG, Patterson PH, Dealwis C, Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15659-64. Epub 2007 Sep 25. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/17895381 17895381] | ||
[[Category: Dealwis, C.]] | [[Category: Dealwis, C.]] | ||
[[Category: Gardberg, A S.]] | [[Category: Gardberg, A S.]] | ||
[[Category: | [[Category: Cdr]] | ||
[[Category: | [[Category: Immune system]] | ||
[[Category: | [[Category: Pfa2]] | ||
[[Category: | [[Category: Wwddd]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 07:46:11 2008'' | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on |